Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Park Medi WorldNSE:PARKHOSPS +1.84%20 EBITDA Margin % is 29.29% as of Mar. 2026, which is 2% above its 10-year median of 28.65. GuruFocus rates NSE:PARKHOSPS with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Park Medi World ranks better than 88.4% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Park Medi World's EBITDA for the
three
months ended in Mar. 2026 was ₹1,349 Mil. Park Medi World's Revenue for the
three
months ended in Mar. 2026 was ₹4,604 Mil. Therefore, Park Medi World's EBITDA margin for the quarter that ended in Mar. 2026 was 29.29%.
Park Medi World (NSE:PARKHOSPS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Park Medi World EBITDA Margin % Related Terms
Park Medi World EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Park Medi World's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:PARKHOSPS vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Park Medi World's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Park Medi World EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Park Medi World's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Park Medi World's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Park Medi World (NSE:PARKHOSPS) has a EBITDA Margin % of 29.29% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Park Medi World and its competitors. This is near median its historical median of 28.65. Over the past decade, Park Medi World's EBITDA Margin % has ranged from 27.52 to 32.32. According to the industry distribution chart, Park Medi World ranks #77 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 11.6%.
Is Park Medi World's EBITDA Margin % too high?
Park Medi World's current EBITDA Margin % of 29.29% is near median its 10-year median of 28.65. Over the past 10 years, this metric has ranged from a low of 27.52 to a high of 32.32. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Park Medi World's value of 29.29% is 186.9% above this industry median. Based on the distribution chart, Park Medi World ranks #77 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Park Medi World has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Park Medi World's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Park Medi World ranks #77 out of 664 companies for EBITDA Margin %. This places Park Medi World in the top 12% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Park Medi World's value of 29.29% is 186.9% above this benchmark. Historically, Park Medi World's own EBITDA Margin % has ranged from 27.52 to 32.32 over the past decade. While the company's 10-year median is 28.65 vs. the industry median of 10.21, Park Medi World has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Park Medi World's current EBITDA Margin % of 29.29% is 186.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Park Medi World and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Park Medi World's current EBITDA Margin % is 29.29%, which is near median its own 10-year median of 28.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Medi World stock overvalued right now?
Park Medi World (NSE:PARKHOSPS) has a current EBITDA Margin % of 29.29%. The current EBITDA Margin % is 29.29%, which is near median its 10-year median of 28.65 and 186.9% above the Healthcare Providers & Services industry median of 10.21. Park Medi World's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Park Medi World (NSE:PARKHOSPS), the current EBITDA Margin % is 29.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Park Medi World Ltd is a private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and a private hospital chain in terms of bed capacity in Haryana with 1,600 beds. The company operates a network of 14 NABH accredited multi-super specialty hospitals under the Park brand, of which eight hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, three hospitals in Punjab and two hospitals in Rajasthan, each committed to providing high-quality and affordable medical services across a diverse range of specialties. It offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology.
20GF Score
Get the complete analysis for NSE:PARKHOSPS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PARKHOSPS has been successfully added to your 
